Evaluation of the economic burden of Herpes Zoster (HZ) infection

References

• JohnsonRW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines2010; 9:Suppl245 - 262; http://dx.doi.org/10.1586/erv.10.30; PMID: 20192714
   PubMedGoogle Scholar
• SteinerI. Herpes virus infection of the peripheral nervous system. Handb Clin Neurol2013; 115:543 - 58; http://dx.doi.org/10.1016/B978-0-444-52902-2.00031-X; PMID: 23931801
   PubMedGoogle Scholar
• WeinbergA, LevinMJ. VZV T cell-mediated immunity. Curr Top Microbiol Immunol2010; 342:341 - 57; http://dx.doi.org/10.1007/82_2010_31; PMID: 20473790
   PubMed Web of Science ®Google Scholar
• GildenD, NagelMA, CohrsRJ, MahalingamR. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep2013; 13:374; http://dx.doi.org/10.1007/s11910-013-0374-z; PMID: 23884722
   PubMedGoogle Scholar
• ThomasSL, HallAJ. What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect Dis2004; 4:26 - 33; http://dx.doi.org/10.1016/S1473-3099(03)00857-0; PMID: 14720565
   PubMed Web of Science ®Google Scholar
• BairdNL, YuX, CohrsRJ, GildenD. Varicella zoster virus (VZV)-human neuron interaction. Viruses2013; 5:2106 - 15; http://dx.doi.org/10.3390/v5092106; PMID: 24008377
   PubMedGoogle Scholar
• ZerboniL, SenN, OliverSL, ArvinAM. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol2014; 12:197 - 210; http://dx.doi.org/10.1038/nrmicro3215; PMID: 24509782
   PubMed Web of Science ®Google Scholar
• GershonAA, GershonMD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev2013; 26:728 - 43; http://dx.doi.org/10.1128/CMR.00052-13; PMID: 24092852
   PubMed Web of Science ®Google Scholar
• Grinde B. Herpesviruses: latency and reactivation - viral strategies and host response. J Oral Microbiol 2013;5.
   Google Scholar
• JohnsonRW, WasnerG, SaddierP, BaronR. Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging2008; 25:991 - 1006; http://dx.doi.org/10.2165/0002512-200825120-00002; PMID: 19021299
   PubMed Web of Science ®Google Scholar
• GuzzettaG, PolettiP, Del FavaE, AjelliM, Scalia TombaGP, MerlerS, ManfrediP. Hope-Simpson’s progressive immunity hypothesis as a possible explanation for herpes zoster incidence data. Am J Epidemiol2013; 177:1134 - 42; http://dx.doi.org/10.1093/aje/kws370; PMID: 23548754
   PubMed Web of Science ®Google Scholar
• Hope-SimpsonRE. The nature of Herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med1965; 58:9 - 20; PMID: 14267505
   PubMedGoogle Scholar
• Hope-SimpsonRE. Epidemiology of shingles. J R Soc Med1991; 84:184; PMID: 20894801
   PubMed Web of Science ®Google Scholar
• OxmanMN. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence. J Am Osteopath Assoc2009; 109:Suppl 2S13 - 7; PMID: 19553630
   PubMedGoogle Scholar
• KawaiK, GebremeskelBG, AcostaCJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open2014; 4:e004833; http://dx.doi.org/10.1136/bmjopen-2014-004833; PMID: 24916088
   PubMed Web of Science ®Google Scholar
• McElhaneyJE. Herpes zoster: a common disease that can have a devastating impact on patients’ quality of life. Expert Rev Vaccines2010; 9:Suppl27 - 30; http://dx.doi.org/10.1586/erv.10.31; PMID: 20192715
   PubMed Web of Science ®Google Scholar
• OpsteltenW, McElhaneyJ, WeinbergerB, OaklanderAL, JohnsonRW. The impact of varicella zoster virus: chronic pain. J Clin Virol2010; 48:Suppl 1S8 - 13; http://dx.doi.org/10.1016/S1386-6532(10)70003-2; PMID: 20510265
   PubMedGoogle Scholar
• BardachA, CafferataML, KleinK, CormickG, GibbonsL, RuvinskyS. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean--a systematic review and meta-analysis. Pediatr Infect Dis J2012; 31:1263 - 8; http://dx.doi.org/10.1097/INF.0b013e31826ff3a5; PMID: 23188098
   PubMed Web of Science ®Google Scholar
• PinchinatS, Cebrián-CuencaAM, BricoutH, JohnsonRW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis2013; 13:170; http://dx.doi.org/10.1186/1471-2334-13-170; PMID: 23574765
   PubMed Web of Science ®Google Scholar
• YawnBP, GildenD. The global epidemiology of herpes zoster. Neurology2013; 81:928 - 30; http://dx.doi.org/10.1212/WNL.0b013e3182a3516e; PMID: 23999562
   PubMed Web of Science ®Google Scholar
• Del ZottiF, GuglielmettiL, ContiM, ValentinottiR, CazzadoriA, ConciaE. [Herpes zoster in general medicine: experience of the Italian group Netaudit]. Infez Med2011; 19:106 - 12; PMID: 21753250
   PubMedGoogle Scholar
• Di LegamiV, GianinoMM, Ciofi degli AttiM, MassariM, MigliardiA, TombaGS, ZottiC, Zoster Study Group. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine2007; 25:7598 - 604; http://dx.doi.org/10.1016/j.vaccine.2007.07.049; PMID: 17889410
   PubMed Web of Science ®Google Scholar
• di Luzio PaparattiU, ArpinelliF, VisonàG. Herpes zoster and its complications in Italy: an observational survey. J Infect1999; 38:116 - 20; http://dx.doi.org/10.1016/S0163-4453(99)90079-8; PMID: 10342652
   PubMed Web of Science ®Google Scholar
• GabuttiG, SerenelliC, CavallaroA, RagniP. Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms. Int J Environ Res Public Health2009; 6:2344 - 53; http://dx.doi.org/10.3390/ijerph6092344; PMID: 19826547
   PubMed Web of Science ®Google Scholar
• GabuttiG, SerenelliC, SarnoO, MarconiS, CorazzaM, VirgiliA. Epidemiologic features of patients affected by herpes zoster: database analysis of the Ferrara University Dermatology Unit, Italy. Med Mal Infect2010; 40:268 - 72; http://dx.doi.org/10.1016/j.medmal.2009.09.005; PMID: 19836913
   PubMed Web of Science ®Google Scholar
• GialloretiLE, DiviziaM, PicaF, VolpiA. Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy. Herpes2005; 12:33 - 7; PMID: 16209858
   PubMedGoogle Scholar
• GialloretiLE, MeritoM, PezzottiP, NaldiL, GattiA, BeillatM, SerradellL, di MarzoR, VolpiA. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis2010; 10:230; http://dx.doi.org/10.1186/1471-2334-10-230; PMID: 20682044
   PubMed Web of Science ®Google Scholar
• SteinAN, BrittH, HarrisonC, ConwayEL, CunninghamA, MacintyreCR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine2009; 27:520 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.11.012; PMID: 19027048
   PubMedGoogle Scholar
• BilckeJ, OgunjimiB, MaraisC, de SmetF, CallensM, CallaertK, van KerschaverE, RametJ, van DammeP, BeutelsP. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect2012; 140:2096 - 109; http://dx.doi.org/10.1017/S0950268811002640; PMID: 22230041
   PubMedGoogle Scholar
• NowgesicE, SkowronskiD, KingA, HockinJ. Direct costs attributed to chickenpox and herpes zoster in British Columbia--1992 to 1996. Can Commun Dis Rep1999; 25:100 - 4; PMID: 10726371
   PubMedGoogle Scholar
• MickG, GallaisJL, SimonF, PinchinatS, BlochK, BeillatM, SerradellL, DerroughT. [Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over]. Rev Epidemiol Sante Publique2010; 58:393 - 401; http://dx.doi.org/10.1016/j.respe.2010.06.166; PMID: 21094001
   PubMed Web of Science ®Google Scholar
• UltschB, KösterI, ReinholdT, SiedlerA, KrauseG, IcksA, SchubertI, WichmannO. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ2013; 14:1015 - 26; http://dx.doi.org/10.1007/s10198-012-0452-1; PMID: 23271349
   PubMed Web of Science ®Google Scholar
• ArpinelliF, BonzaniniAC, VisonàG. La gestione clinica ed i costi dell’Herpes Zoster in Italia. G Farmacoeconomia2000; 3:98 - 103
   Google Scholar
• ChoiWS, NohJY, HuhJY, JoYM, LeeJ, SongJY, KimWJ, CheongHJ. Disease burden of herpes zoster in Korea. J Clin Virol2010; 47:325 - 9; http://dx.doi.org/10.1016/j.jcv.2010.01.003; PMID: 20181512
   PubMedGoogle Scholar
• ChoiWS, KwonSS, LeeJ, ChoiSM, LeeJS, EomJS, SohnJW, ChoengHJ. Immunity and the burden of herpes zoster. J Med Virol2014; 86:525 - 30; http://dx.doi.org/10.1002/jmv.23830; PMID: 24166660
   PubMedGoogle Scholar
• Cebrián-CuencaAM, Díez-DomingoJ, San-Martín-RodríguezM, Puig-BarberáJ, Navarro-PérezJ, Herpes Zoster Research Group of the Valencian Community. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis2011; 11:302; http://dx.doi.org/10.1186/1471-2334-11-302; PMID: 22044665
   PubMed Web of Science ®Google Scholar
• GilA, GilR, AlvaroA, San MartínM, GonzálezA. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis2009; 9:55; http://dx.doi.org/10.1186/1471-2334-9-55; PMID: 19422687
   PubMed Web of Science ®Google Scholar
• Sicras-MainarA, Navarro-ArtiedaR, Ibáñez-NollaJ, Pérez-RoncoJ. [Incidence, resource use and costs associated with postherpetic neuralgia: a population-based retrospective study]. Rev Neurol2012; 55:449 - 61; PMID: 23055426
   PubMed Web of Science ®Google Scholar
• JihJS, ChenYJ, LinMW, ChenYC, ChenTJ, HuangYL, ChenCC, LeeDD, ChangYT, WangWJ, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol2009; 89:612 - 6; http://dx.doi.org/10.2340/00015555-0729; PMID: 19997693
   PubMed Web of Science ®Google Scholar
• LinYH, HuangLM, ChangIS, TsaiFY, LuCY, ShaoPL, ChangLY, Varicella-Zoster Working Group, Advisory Committee on Immunization Practices, Taiwan. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine2010; 28:1217 - 20; http://dx.doi.org/10.1016/j.vaccine.2009.11.029; PMID: 19944790
   PubMed Web of Science ®Google Scholar
• AunhachokeK, BussaratidV, ChirachanakulP, Chua-IntraB, DhitavatJ, JaisathapornK, KaewkungwalJ, KampirapapK, KhuhapremaT, PairayayutakulK, et al, Thai Herpes Zoster Study Group. Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand. Int J Dermatol2011; 50:428 - 35; http://dx.doi.org/10.1111/j.1365-4632.2010.04715.x; PMID: 21413953
   PubMedGoogle Scholar
• DaviesL, CossinsL, BowsherD, DrummondM. The cost of treatment for post-herpetic neuralgia in the UK. Pharmacoeconomics1994; 6:142 - 8; http://dx.doi.org/10.2165/00019053-199406020-00006; PMID: 10147439
   PubMedGoogle Scholar
• GauthierA, BreuerJ, CarringtonD, MartinM, RémyV. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect2009; 137:38 - 47; http://dx.doi.org/10.1017/S0950268808000678; PMID: 18466661
   PubMed Web of Science ®Google Scholar
• ScottFT, JohnsonRW, Leedham-GreenM, DaviesE, EdmundsWJ, BreuerJ. The burden of Herpes Zoster: a prospective population based study. Vaccine2006; 24:1308 - 14; http://dx.doi.org/10.1016/j.vaccine.2005.09.026; PMID: 16352376
   PubMed Web of Science ®Google Scholar
• DworkinRH, WhiteR, O’ConnorAB, BaserO, HawkinsK. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. J Am Geriatr Soc2007; 55:1168 - 75; http://dx.doi.org/10.1111/j.1532-5415.2007.01231.x; PMID: 17661954
   PubMed Web of Science ®Google Scholar
• DworkinRH, WhiteR, O’ConnorAB, HawkinsK. Health care expenditure burden of persisting herpes zoster pain. Pain Med2008; 9:348 - 53; http://dx.doi.org/10.1111/j.1526-4637.2006.00196.x; PMID: 18366512
   PubMed Web of Science ®Google Scholar
• DworkinRH, MaloneDC, PanaritesCJ, ArmstrongEP, PhamSV. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. J Pain2010; 11:360 - 8; http://dx.doi.org/10.1016/j.jpain.2009.08.005; PMID: 19853529
   PubMed Web of Science ®Google Scholar
• InsingaRP, ItzlerRF, PellissierJM. Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans. Pharmacoeconomics2007; 25:155 - 69; http://dx.doi.org/10.2165/00019053-200725020-00007; PMID: 17249857
   PubMed Web of Science ®Google Scholar
• JohnstonSS, UdallM, AlvirJ, McMorrowD, FowlerR, MullinsD. Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia. Pain Med2014; 15:562 - 76; http://dx.doi.org/10.1111/pme.12328; PMID: 24433487
   PubMed Web of Science ®Google Scholar
• KirsonNY, IvanovaJI, BirnbaumHG, WeiR, KantorE, Amy PuenpatomR, Ben-JosephRH, SummersKH. Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%. J Med Econ2010; 13:472 - 81; http://dx.doi.org/10.3111/13696998.2010.499819; PMID: 20684670
   PubMedGoogle Scholar
• KirsonNY, IvanovaJI, BirnbaumHG, WeiR, KantorE, PuenpatomRA, Ben-JosephRH, SummersKH. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. J Med Econ2010; 13:482 - 91; http://dx.doi.org/10.3111/13696998.2010.506176; PMID: 20684669
   PubMedGoogle Scholar
• LinF, HadlerJL. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis2000; 181:1897 - 905; http://dx.doi.org/10.1086/315492; PMID: 10837168
   PubMed Web of Science ®Google Scholar
• MaL, WhiteRR, NarayananS, SchmaderKE. Economic burden of herpes zoster among skilled nursing facility residents in the United States. J Am Med Dir Assoc2012; 13:54 - 9; http://dx.doi.org/10.1016/j.jamda.2010.03.015; PMID: 21450176
   PubMedGoogle Scholar
• PalmerL, WhiteRR, JohnsonBH, FowlerR, AcostaCJ. Herpes zoster-attributable resource utilization and cost burden in patients with solid organ transplant. Transplantation2014; 97:1178 - 84; http://dx.doi.org/10.1097/01.tp.0000441826.70687.f6; PMID: 24892964
   PubMed Web of Science ®Google Scholar
• PatelMS, GebremariamA, DavisMM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol2008; 29:1157 - 63; http://dx.doi.org/10.1086/591975; PMID: 18999945
   PubMed Web of Science ®Google Scholar
• SinghalPK, MakinC, PellissierJ, SyL, WhiteR, SaddierP. Work and productivity loss related to herpes zoster. J Med Econ2011; 14:639 - 45; http://dx.doi.org/10.3111/13696998.2011.607482; PMID: 21838599
   PubMedGoogle Scholar
• WhiteRR, LenhartG, SinghalPK, InsingaRP, ItzlerRF, PellissierJM, SegravesAW. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics2009; 27:781 - 92; http://dx.doi.org/10.2165/11317560-000000000-00000; PMID: 19757871
   PubMed Web of Science ®Google Scholar
• YawnBP, ItzlerRF, WollanPC, PellissierJM, SyLS, SaddierP. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc2009; 84:787 - 94; http://dx.doi.org/10.4065/84.9.787; PMID: 19720776
   PubMed Web of Science ®Google Scholar
• GildenD. Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. J Intern Med2011; 269:496 - 506; http://dx.doi.org/10.1111/j.1365-2796.2011.02359.x; PMID: 21294791
   PubMed Web of Science ®Google Scholar
• KeatingGM. Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years. Drugs2013; 73:1227 - 44; http://dx.doi.org/10.1007/s40265-013-0088-1; PMID: 23839657
   PubMedGoogle Scholar
• SanfordM, KeatingGM. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Drugs Aging2010; 27:159 - 76; http://dx.doi.org/10.2165/10489140-000000000-00000; PMID: 20104941
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Shingles Vaccination: What You Need to Know. Available at: http://www.cdc.gov/vaccines/vpd-vac/shingles/vacc-need-know.htm Accessed 14, 2014.
   Google Scholar
• MorrisonVA, OxmanMN, LevinMJ, SchmaderKE, GuatelliJC, BettsRF, GelbLD, PachuckiCT, KeaySK, MenziesB, et al, Shingles Prevention Study Group. Safety of zoster vaccine in elderly adults following documented herpes zoster. J Infect Dis2013; 208:559 - 63; http://dx.doi.org/10.1093/infdis/jit182; PMID: 23633406
   PubMed Web of Science ®Google Scholar
• WeaverBA, Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention. Update on the advisory committee on immunization practices’ recommendations for use of herpes zoster vaccine. J Am Osteopath Assoc2011; 111:Suppl 6S31 - 3; PMID: 22086893
   PubMedGoogle Scholar
• SzucsTD, PfeilAM. A systematic review of the cost effectiveness of herpes zoster vaccination. Pharmacoeconomics2013; 31:125 - 36; http://dx.doi.org/10.1007/s40273-012-0020-7; PMID: 23335045
   PubMed Web of Science ®Google Scholar
• van HoekAJ, MelegaroA, GayN, BilckeJ, EdmundsWJ. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine2012; 30:1225 - 34; http://dx.doi.org/10.1016/j.vaccine.2011.11.026; PMID: 22119592
   PubMed Web of Science ®Google Scholar
• LiberatiA, AltmanDG, TetzlaffJ, MulrowC, GøtzschePC, IoannidisJP, ClarkeM, DevereauxPJ, KleijnenJ, MoherD. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med2009; 6:e1000100; http://dx.doi.org/10.1371/journal.pmed.1000100; PMID: 19621070
   PubMed Web of Science ®Google Scholar
• HusereauD, DrummondM, PetrouS, CarswellC, MoherD, GreenbergD, AugustovskiF, BriggsAH, MauskopfJ, LoderE, CHEERS Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ2013; 346:f1049; http://dx.doi.org/10.1136/bmj.f1049; PMID: 23529982
   PubMed Web of Science ®Google Scholar
• Manager R. (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
   Google Scholar